Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.
about
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of ageSubclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in childrenSalivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines.Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.New pneumococcal vaccines for children.Development of Vi conjugate - a new generation of typhoid vaccine.Current state of pneumococcal vaccines.Effects of sample collection and storage methods on antipneumococcal immunoglobulin A in salivaMucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.Prospects for a vaccine against otitis media.Towards Universal Screening for Toxoplasmosis: Rapid, Cost-Effective, and Simultaneous Detection of Anti-Toxoplasma IgG, IgM, and IgA Antibodies by Use of Very Small Serum Volumes.Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens.Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.The utility of saliva for the assessment of anti-pneumococcal antibodies: investigation of saliva as a marker of antibody status in serum.Salivary Functional Antibody Secretion Is Reduced in Older Adults: A Potential Mechanism of Increased Susceptibility to Bacterial Infection in the Elderly.Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy.A milestone in the investigation of population-wide effects of vaccines.Anticapsular Serum Antibody Concentration and Protection against Pneumococcal Colonization among Children Vaccinated with 7-Valent Pneumococcal Conjugate Vaccine
P2860
Q24245934-BD42218A-5AD6-4766-982D-C67E276F0FD5Q24684017-29526AB3-34D4-40A1-B57E-26AE2C53330FQ24812739-23F7CFCC-F709-4987-8703-5F53FB476F2EQ28187952-C51CA9CA-D49E-488B-8336-72F3D5F0AB8AQ30665602-68E37D08-7C18-40EE-ABB3-C1B18121C7ADQ33619565-DB657DEF-2447-485E-88D9-F20EF6980182Q34170021-7C8559D5-360A-4209-8953-ECFAEEBBC0E7Q34190093-C56716CA-DAEC-4EDF-A59D-E9E6F6ABB636Q34380025-C1C6B3A0-1DA5-47CC-A1EB-3D307FEB0BF2Q34744239-DA0EA865-0A08-40E7-97F9-3B26DFC7CFF6Q34995650-D2043B21-080B-4748-8196-CA183FFFD4AFQ35588006-2F38475A-2C3F-4A3C-AE50-E5A0946AF2C2Q36600356-36AA4571-9EEC-4658-8006-85D197348C62Q37040526-4358EB2F-6E37-4522-9845-01F80E594272Q39339128-7D49ED81-4C04-4ECD-9252-2ACDD234A9ADQ39521131-63026ABA-4DA0-4126-9806-0EBA896CC529Q39656521-6950D134-4764-4C4E-8252-50A797D6782DQ40436316-5D342ED4-F7F4-4897-B8D6-DE65F620E5E6Q41021466-30E6EED1-8C22-455E-85D0-920A6EA98541Q42123701-A130F9C3-3C62-45DA-9454-A5888D4DADC5Q48125700-6280A27C-30B9-440B-8D03-9570D4F84E9DQ58097241-8181AD52-66EC-4738-BF48-06D32BC07DBD
P2860
Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Primary and booster salivary a ...... conjugate vaccine in infants.
@en
Primary and booster salivary a ...... conjugate vaccine in infants.
@nl
type
label
Primary and booster salivary a ...... conjugate vaccine in infants.
@en
Primary and booster salivary a ...... conjugate vaccine in infants.
@nl
prefLabel
Primary and booster salivary a ...... conjugate vaccine in infants.
@en
Primary and booster salivary a ...... conjugate vaccine in infants.
@nl
P2093
P356
P1476
Primary and booster salivary a ...... conjugate vaccine in infants.
@en
P2093
P304
P356
10.1086/315834
P407
P577
2000-08-31T00:00:00Z